
AdaptHealth Corp. AHCO
$ 8.9
-13.51%
Annual report 2025
added 02-24-2026
AdaptHealth Corp. Interest Expense 2011-2026 | AHCO
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense AdaptHealth Corp.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -274 K | -2.79 M | -29.6 M | -253 K | 95.2 M | 41.4 M | 39.3 M | 7.45 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 95.2 M | -29.6 M | 18.8 M |
Quarterly Interest Expense AdaptHealth Corp.
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 1.76 M | -5.1 M | - | -3.32 M | -2.08 M | 32 M | - | 28.5 M | 25.6 M | 24.8 M | - | 24.3 M | 23.1 M | 22.2 M | - | 12.4 M | 7.48 M | 7.94 M | - | 10.8 M | 14.6 M | 6.26 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 32 M | -5.1 M | 13.6 M |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AxoGen
AXGN
|
167 K | $ 32.5 | -8.14 % | $ 1.44 B | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
Aziyo Biologics
AZYO
|
5.8 M | - | 1.37 % | $ 20.5 M | ||
|
Alphatec Holdings
ATEC
|
45.9 M | $ 13.77 | 4.86 % | $ 1.97 B | ||
|
Bio-Rad Laboratories
BIO
|
48.9 M | $ 269.87 | 0.53 % | $ 7.61 B | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
Apyx Medical Corporation
APYX
|
2.48 M | $ 3.53 | -1.12 % | $ 122 M | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
ClearPoint Neuro
CLPT
|
-40 K | $ 14.58 | -1.22 % | $ 394 M | ||
|
Cognyte Software Ltd.
CGNT
|
-1.61 M | $ 6.36 | 0.32 % | $ 457 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 39.87 | 0.77 % | $ 5.94 K | ||
|
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
349 M | $ 75.27 | 1.21 % | $ 111 B | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 4.52 | - | $ 169 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Electromed
ELMD
|
78 K | $ 23.17 | -5.16 % | $ 196 M | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 46.0 | 1.39 % | $ 1.43 B | ||
|
Second Sight Medical Products
EYES
|
1.19 M | - | -0.97 % | $ 54.4 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | ||
|
Delcath Systems
DCTH
|
-30 K | $ 9.94 | 2.0 % | $ 283 M | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
Establishment Labs Holdings
ESTA
|
-15.3 M | $ 78.78 | 5.1 % | $ 2.22 B | ||
|
IRadimed Corporation
IRMD
|
164 K | $ 99.04 | -2.22 % | $ 1.25 B | ||
|
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | ||
|
FONAR Corporation
FONR
|
347 K | $ 18.55 | -0.22 % | $ 122 M | ||
|
Globus Medical
GMED
|
3.41 M | $ 92.25 | -1.25 % | $ 12.5 B | ||
|
LivaNova PLC
LIVN
|
1.01 M | $ 69.26 | 1.32 % | $ 3.76 B | ||
|
Pulmonx Corporation
LUNG
|
256 K | $ 1.51 | 2.03 % | $ 59.1 M | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 1.88 | - | $ 1.14 M | ||
|
Medtronic PLC
MDT
|
402 M | $ 97.06 | -1.57 % | $ 125 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
3.94 M | $ 11.57 | -1.66 % | $ 891 M | ||
|
MiMedx Group
MDXG
|
-565 K | $ 5.35 | 0.28 % | $ 786 M |